Track Frequency Therapeutics's current cash ($40M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Frequency Therapeutics (FREQ) currently reports a current cash of $40M as of September 2026. That compares with $24M in the prior-year period — up 66.5% year over year. Use the charts on this page to explore Frequency Therapeutics's current cash history and peer comparisons.
Frequency Therapeutics's current cash increased from $24M to $40M — a 66.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Frequency Therapeutics reported $40M in current cash as of September 2026. That compares with $24M in the prior-year period — up 66.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frequency Therapeutics, and consider following FREQ for alerts when major investors trade the stock.
Frequency Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FREQ with unrelated industries.